Key result
Concomitant digitalis use during direct current cardioversion for atrial fibrillation shows uncertain safety outcomes.
Why the study?
The combined use of digitalis and direct current shock in treating ectopic tachycardias can lead to undesirable complications and requires evaluation.
What are the clinical and experimental effects and complications of the combined use of digitalis and direct current shock in patients with atrial fibrillation?
Observational (n=289)
What are the clinical and experimental effects and complications of the combined use of digitalis and direct current shock in patients with atrial fibrillation?
This study evaluates the clinical and experimental effects and potential complications of combining digitalis with direct current shock for the treatment of atrial fibrillation.
Concomitant digitalis with DC shock risks complications; leaves open safe periprocedural protocols in tachyarrhythmias.
The application of direct current (DC) shock is now an established method of treatment of ectopic tachycardias.However, experience has shown that the concomitant use of certain cardiac drugs can lead to undesirable complications and create new problems in the management of the patient.Several studies have already referred to the use of digitalis (Gilbert and Cuddy, 1965; Lown, Kleiger, and Williams, 1965; Kleiger and Lown, 1966; Szekely, Wynne, and Batson, 1966b; Lown, 1967; Castellanos et al., 1967) in association with DC shock therapy.It is the purpose of this paper to evaluate clinical and experimental observations on the effects of the combined use of digitalis and DC shock.Clinical and experimental observations on the concomitant use of various antiarrhythmic drugs and DC shock will be the subject of a separate communication. METHOD, CLINICAL GROUPS, AND EXPERIMENTAL MATERIAL(A) Clinical.Five hundred consecutive episodes of ectopic tachycardia treated by DC shock have been reviewed.Of these, 414 episodes of atrial fibrillation occurring in 289 patients form the basis of the present observations.Of the 289, 218 patients had rheumatic heart disease, 30 coronary heart disease with or without hypertension, 4 congenital heart disease, 9 thyrotoxicosis, 1 had chronic pulmonary heart disease, and there were 27 patients with no firm clinical diagnosis, several of whom were suspected to have cardiomyopathy.In 369 episodes of atrial fibrillation the following drugs were used singly or in combination at the time of DC shock therapy: digitalis, quinidine, procainamide, and pro- pranolol.In the remaining 45 episodes no drugs were used at all.The method of DC shock therapy and the results of the first 200 episodes have already been re- ported in a previous paper (Szekely, Batson, and Stark, 1966a).Only the method of anaesthesia has since been modified.After abandoning pentothal, methohexitone
No takes yet. Share an insight, caveat, or question.
Szekely et al. (1969) conducted an observational in Atrial fibrillation (n=289). Concomitant digitalis and direct current shock vs. Direct current shock without digitalis was evaluated. A cohort of 289 patients treated with direct current shock for atrial fibrillation was reviewed to evaluate the effects of concomitant digitalis use, though no quantitative results are reported in the abstract.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: